Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19752363 | 0.82 | GAA (0.33) | ALDH1A1MEN1KMT2AHTR7POLB | |
| SCHEMBL19885349 | 0.71 | KMT2A (0.52) | ALDH1A1KDM4ELMNAMEN1KMT2A | |
| SCHEMBL11921038 | 0.71 | MEN1 (0.34) | ALDH1A1KDM4ELMNANPSR1MEN1 | |
| SCHEMBL19999692 | 0.69 | ALDH1A1 (0.39) | ALDH1A1KDM4ELMNANPSR1MEN1 | |
| SCHEMBL21074258 | 0.69 | ALDH1A1 (0.39) | ALDH1A1KDM4ELMNANPSR1MEN1 | |
| SCHEMBL9891022 | 0.69 | ALDH1A1 (0.36) | ALDH1A1LMNAMEN1KMT2APOLB | |
| SCHEMBL12083455 | 0.69 | ALDH1A1 (0.36) | ALDH1A1LMNAMEN1KMT2APOLB | |
| SCHEMBL19680274 | 0.68 | DPP4 (0.34) | ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL20693378 | 0.67 | GPR3 (0.49) | ALDH1A1KDM4ELMNANPSR1MEN1 | |
| SCHEMBL18708643 | 0.66 | HTR2C (0.33) | ALDH1A1MEN1KMT2AHTR7POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4282863-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2023-11-29 | — | — | EP | disclosed |
| EP-3843171-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2023-09-27 | — | — | EP | disclosed |
| US-11692131-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes | UDC IRELAND LIMITED (IE) | 2023-07-04 | — | — | US | disclosed |
| US-10385263-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes (OLEDS) | UDC IRELAND LIMITED (IE) | 2019-08-20 | — | — | US | disclosed |
| US-8383828-B2 | Transition metal complexes comprising one noncarbene ligand and one or two carbene ligands and their use in OLEDs | BASF AKTIENGESELLSCHAFT (DE) | 2013-02-26 | — | — | US | disclosed |
| US-20090096367-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20090054657-A1 | Transition Metal Complexes Comprising One Noncarbene Ligand and One or Two Carbene Ligands and their Use in Oleds | BASF SE (DE) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090096367-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) | OCIAD2, OCIAD1, ICOSLG | ALDH1A1 1119/4885KDM4E 4501/4885LMNA 4236/4885 |
| US-20090054657-A1 | Transition Metal Complexes Comprising One Noncarbene Ligand and One or Two Carbene Ligands and their Use in Oleds | OCIAD1, OCIAD2, ICOSLG | ALDH1A1 1163/4885KDM4E 4609/4885LMNA 3890/4885 |
| US-11692131-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes | CLTB, CLTC, CYBA | ALDH1A1 1498/4885KDM4E 3984/4885LMNA 4022/4885 |
| US-10385263-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes (OLEDS) | OCIAD2, OCIAD1, ICOSLG | ALDH1A1 1119/4885KDM4E 4501/4885LMNA 4236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.